Abstract:Problem definition: In many service operations, customers have repeated interactions with service providers. This creates two important questions for service design. First, how important is it to maintain the continuity of service for individuals? Second, because maintaining continuity is costly and, at times, operationally impractical for both the organization (because of potentially lower utilization) and providers (because of high effort required), should certain customer types, such as those with complex n… Show more
“…Meanwhile, researchers have recently started to explore the potential benefits of variation when introduced within the care pathway of an individual patient (Ahuja et al 2020, Chan et al 2019, Kuntz et al 2019. Especially for medical conditions where multiple viable treatment options exist, patients may benefit from exposure to a variety of providers and treatment options as they search for the best solution to their problems (Christensen et al 2009).…”
Section: Related Literaturementioning
confidence: 99%
“…This concept of routing during the early stages of opioid use is also related to studies on continuity of care. Such work typically focuses on the long-term management of patients who are already suffering from specific chronic conditions, e.g., heart failure (Senot 2019), diabetes (Ahuja et al 2020), or opioid dependence (Hallvik et al 2018). While most studies in these chronic settings find that patients benefit from repeated appointments with the same practitioner, we focus on patients prior to chronicity.…”
Section: Related Literaturementioning
confidence: 99%
“…In medical settings, clinician discordance is generally recognized to confer two main advantages. First, combining the knowledge pools of two clinicians enlarges the information base used in decision-making (Ahuja et al 2020, the patient that proves important in weighing the trade-offs between potential treatments. This new perspective may be particularly important for the early stages of opioid use given the array of clinically viable treatment options available for pain management (Owen et al 2018).…”
Section: The Effect Of Provider Discordancementioning
confidence: 99%
“…For those patients who continue seeking treatment in the primary care setting after opioid initiation, we therefore ask: who should revisit the treatment plan with the patient, the original prescriber (i.e., provider concordance) or another clinician (i.e., provider discordance)? 1 While a different clinician can expose the patient to a "fresh perspective" and prevent anchoring to the original opioid treatment course, it may also lead to more fragmented care and reduce physician "ownership" of the long-term health of the patient (Ahuja et al 2020, Ariely et al 2003, Senot 2019. Although prescriber continuity is typically recommended for patients already dependent on opioids (Hallvik et al 2018, Jena et al 2014, the overall impact of exposing a patient to variation in providers in the initial stages of opioid use is not immediately clear.…”
Although medical research has addressed the clinical management of chronic opioid users, little is known about how operational interventions shortly after opioid initiation can impact a patient’s likelihood of long-term opioid use. Using a nationwide U.S. database of medical and pharmaceutical claims, we investigate the care delivery process at the most common entry point to opioid use: the primary care setting. For patients who return to primary care for a follow-up appointment within 30 days of opioid initiation, we ask who should revisit and potentially revise the opioid-based treatment plan: the initial prescriber (provider concordance) or an alternate clinician (provider discordance)? First, using a fully controlled logistic model, we find that provider discordance reduces the likelihood of long-term opioid use 12 months after opioid initiation by 31% (95% Confidence Interval: [18%, 43%]). Both the instrumental variable analysis technique and propensity-score matching (utilizing the minimum-bias estimator approach) account for omitted variable bias and indicate that this is a conservative estimate of the true causal effect. Second, looking at patient activities immediately after the follow-up appointment, we find that this long-term reduction is at least partially explained by an immediate reduction in opioids prescribed after the follow-up appointment. Third, the data suggest that the benefit associated with provider discordance remains significant regardless of whether the patient’s initial prescriber was their regular primary care provider or another clinician. Overall, our analysis indicates that systematic, operational changes in the early stages of managing new opioid patients may offer a promising, and hitherto overlooked, opportunity to curb the opioid epidemic. This paper was accepted by David Simchi-Levi, healthcare management.
“…Meanwhile, researchers have recently started to explore the potential benefits of variation when introduced within the care pathway of an individual patient (Ahuja et al 2020, Chan et al 2019, Kuntz et al 2019. Especially for medical conditions where multiple viable treatment options exist, patients may benefit from exposure to a variety of providers and treatment options as they search for the best solution to their problems (Christensen et al 2009).…”
Section: Related Literaturementioning
confidence: 99%
“…This concept of routing during the early stages of opioid use is also related to studies on continuity of care. Such work typically focuses on the long-term management of patients who are already suffering from specific chronic conditions, e.g., heart failure (Senot 2019), diabetes (Ahuja et al 2020), or opioid dependence (Hallvik et al 2018). While most studies in these chronic settings find that patients benefit from repeated appointments with the same practitioner, we focus on patients prior to chronicity.…”
Section: Related Literaturementioning
confidence: 99%
“…In medical settings, clinician discordance is generally recognized to confer two main advantages. First, combining the knowledge pools of two clinicians enlarges the information base used in decision-making (Ahuja et al 2020, the patient that proves important in weighing the trade-offs between potential treatments. This new perspective may be particularly important for the early stages of opioid use given the array of clinically viable treatment options available for pain management (Owen et al 2018).…”
Section: The Effect Of Provider Discordancementioning
confidence: 99%
“…For those patients who continue seeking treatment in the primary care setting after opioid initiation, we therefore ask: who should revisit the treatment plan with the patient, the original prescriber (i.e., provider concordance) or another clinician (i.e., provider discordance)? 1 While a different clinician can expose the patient to a "fresh perspective" and prevent anchoring to the original opioid treatment course, it may also lead to more fragmented care and reduce physician "ownership" of the long-term health of the patient (Ahuja et al 2020, Ariely et al 2003, Senot 2019. Although prescriber continuity is typically recommended for patients already dependent on opioids (Hallvik et al 2018, Jena et al 2014, the overall impact of exposing a patient to variation in providers in the initial stages of opioid use is not immediately clear.…”
Although medical research has addressed the clinical management of chronic opioid users, little is known about how operational interventions shortly after opioid initiation can impact a patient’s likelihood of long-term opioid use. Using a nationwide U.S. database of medical and pharmaceutical claims, we investigate the care delivery process at the most common entry point to opioid use: the primary care setting. For patients who return to primary care for a follow-up appointment within 30 days of opioid initiation, we ask who should revisit and potentially revise the opioid-based treatment plan: the initial prescriber (provider concordance) or an alternate clinician (provider discordance)? First, using a fully controlled logistic model, we find that provider discordance reduces the likelihood of long-term opioid use 12 months after opioid initiation by 31% (95% Confidence Interval: [18%, 43%]). Both the instrumental variable analysis technique and propensity-score matching (utilizing the minimum-bias estimator approach) account for omitted variable bias and indicate that this is a conservative estimate of the true causal effect. Second, looking at patient activities immediately after the follow-up appointment, we find that this long-term reduction is at least partially explained by an immediate reduction in opioids prescribed after the follow-up appointment. Third, the data suggest that the benefit associated with provider discordance remains significant regardless of whether the patient’s initial prescriber was their regular primary care provider or another clinician. Overall, our analysis indicates that systematic, operational changes in the early stages of managing new opioid patients may offer a promising, and hitherto overlooked, opportunity to curb the opioid epidemic. This paper was accepted by David Simchi-Levi, healthcare management.
“…The term ‘remote health’ is often combined with the term ‘rural health’, but remote health has distinct characteristics (Ahuja et al, 2020). Compared with rural health, remote health refers to settings with greater distances and geographical isolation, less access to health care, less availability of services, and smaller and more mobile populations with a higher percentage of Indigenous residents.…”
Aim:The aim of this study was to examine the perspectives of experienced Australian remote area nurses about remote nursing staff retention strategies.Background: There is low retention of remote area nurses in remote Australia.Retention of remote area nurses can be improved by a supportive environment including good management, professional development and supervision.Method: This is a qualitative study using in-depth interviews with seven registered nurses with a minimum of 3 years remote area nursing experience. Participants were interviewed by phone, with the interviews audio-recorded then transcribed and analysed thematically.Results: Participants had on average 12 years of experience as a remote area nurse.They valued teamwork, effective and flexible management practices and the ability to maintain their own cultural and social connectedness. A flexible service model with regular short breaks, filled by returning agency nurses to enable continuity of care and cultural connections, was seen as a viable approach.
Conclusion:Flexible management practices that encourage short breaks for remote area nurses may increase retention. This would need to occur within a supportive management framework.Implications for Nursing Management: Management strategies that reduce isolation from personal and social networks can increase the retention of skilled remote area nurses.management, remote area nurses, remote health, retention, workforce 1 | BACKGROUND
| Remote health practice and RANsThe term 'remote health' is often combined with the term 'rural health', but remote health has distinct characteristics (Ahuja et al., 2020). Compared with rural health, remote health refers to settings with greater distances and geographical isolation, less access to health care, less availability of services, and smaller and more mobile populations with a higher percentage of Indigenous residents. Also, remote health services use different models of health care delivery, with health professionals generally being employed by state, territory health services or Aboriginal and Torres Strait Islander Health Organisations, rather than the small hospitals with local GPs practices in rural areas. In a remote health context, the social dimensions are also different with less power and
Health promotion and disease prevention requires health systems address the patients' social needs using new care delivery models. Yet, research in this area has stalled for several reasons. We study a partnership model of care that couples clinical care delivered by primary care providers and social services delivered by community‐based organizations, and its impact on patients' preventive health outcomes and behaviors. We use data from the Mid‐Ohio Farmacy, which is a collaboration across the Mid‐Ohio Food Collective (MOFC), a network of 650+ affiliated food pantries, and a large federally qualified health center (FQHC). The FQHC offers primary and preventative healthcare services across eight free clinics, which are co‐located with the MOFC‐affiliated food pantries. Patients were screened for food insecurity during their clinic visit and, if positive, were referred to the Farmacy. Compliers made at least one visit to the food pantry after referral, while noncompliers did not. Using difference‐in‐differences, we find that compliers had no discernible change in their body mass index (BMI, kg/m2), which we refer to as a BMI stabilization effect. Noncompliers' BMI increased after referral. High comorbid and high pantry use compliers experienced a significant reduction in their BMI and a marginally significant reduction in glycated hemoglobin (HbA1c, %). These patients had unique compliance behaviors, including greater search, frequency, and consistency of food pantry use. Travel costs suggests that high comorbid patients ascribed a greater value to the Farmacy program. In terms of primary care utilization, we find that compliers' clinic visit patterns after referral were consistent with the visit patterns observed in the food secure cohort, suggesting that the Farmacy program may have helped compliers address competing demands that are known to inhibit health behaviors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.